Predictive echo-Doppler indices of left ventricular impairment in B-thalassemic patients

Annals of Hematology

Volumn 86, Issue 6, 2007, Pages 429-434

  Aessopos, Athanassios ^a   Deftereos, Spyros ^a   Tsironi, Maria ^a,b,c   Karabatsos, Fotios ^a   Yousef, Jacqueline ^a   Fragodimitri, Christina ^a   Hatziliami, Antonia ^a   Karagiorga, Markissia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Sparta General Hospital ^*  (Greece)

^c Department of Internal Medicine   (Greece)

Author keywords

thalassemia; Chelation; Echo cardiography; Heart dysfunction

Indexed keywords

DEFEROXAMINE; FERRITIN; HEMOGLOBIN;

A WAVE; ADULT; AGE; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE SIZE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; BETA-THALASSEMIA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247335101     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0257-y     Document Type: Article

References (28)

1. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J et al (2004) Cardiac status in well-treated patients with thalassemia major. Eur J Haematol 73(5):359-366
2. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, Diamanti-Kandaraki E, Papalambros E (2005) Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia. Ann Hematol 84(6):353-357 (Epub 2005 Feb 12, Jun)
3. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B et al (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: A prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127(3):348-355
4. Ashena Z, Ghafurian S, Ehsani MA (2007) The relation between left ventricular diastolic indices and serum ferritin in thalassemia major. Pediatr Hematol Oncol 24(1):3-14 (Jan-Feb)
5. Borer JS, Henry WL, Epstein SE (1977) Echocardiographic observations in patients with systemic infiltrative disease involving the heart. Am J Cardiol 39(2):184-188
6. Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR et al (1998) Survival and disease complications in thalassemia major. Ann N Y Acad Sci 850:227-231
7. Borgna Pignatti C, Cappellini MD, De Stefano P, Del Vecchio G, Forni G, Gamberini M, Ghilardi M, Piga A, Romeo M, Zhao H, Cnaan A (2006) Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major. Blood 107(9):3733-3737
8. Braunwald E, Zipes D, Libby P (2001) Heart disease, 6th (edn). Saunders, Philadelphia, PA
9. Brittenham GM, Badman DG (2003) National institute of diabetes and digestive and kidney diseases (NIDDK) workshop. Noninvasive measurement of iron: Report of an NIDDK workshop. Blood 101(1):15-19 (Epub 2002 Aug 29, Jan 1)
10. Daar S, Pathare AV (2006) Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol 85(5):315-319 (Epub 2006 Feb 1, May)
11. Deftereos S, Lambrinoudakis C, Andriopoulos P, Farmakis D, Aessopos A (2001) A java-based electronic healthcare record software for beta-thalassaemia. J Med Internet Res 3(4):e33, http://www.jmir.org/2001/ 4/e33/
12. Economou-Petersen E, Aessopos A, Kladi A, Flevari P, Karabatsos F, Fragodimitri C et al (1998) Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood 92(9):3455-3459
13. Ehlers KH, Levin AR, Markenson AL, Marcus JR, Klein AA, Hilgartner MW et al (1980) Longitudinal study of cardiac function in thalassemia major. Ann N Y Acad Sci 344:397-404
14. Feigenbaum H (1994) Echocardiography, 5th (edn). Lea & Febiger, Philadelphia
15. Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola L, Coppola A, Iarussi D, Esposito L (2001) Role of apolipoprotein E (APOE) polymorphism on left cardiac failure in homozygous beta thalassaemic patients. Br J Haematol 114(4):959-960 (September)
16. Hahalis G, Manolis AS, Apostolopoulos D, Alexopoulos D, Vagenakis AG, Zoumbos NC (2002) Right ventricular cardiomyopathy in beta-thalassaemia major. Eur Heart J 23:147-156
17. Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ (2006) Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*. Hemoglobin 30(2):219-227
18. Kremastinos DT, Tsiapras DP, Tsetsos GA, Rentoukas EI, Vretou HP, Toutouzas PK (1993) Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation 88:1127-1135
19. Olivieri NF, Brittenham GM (1997) Iron-chelating therapy and the treatment of thalassemia. Blood 89:739-761
20. Olivieri NF (1999) The beta-thalassemias. N Engl J Med 341:99-109
21. Olson LJ, Baldus WP, Tajik AJ (1987) Echocardiographic features of idiopathic hemochromatosis. Am J Cardiol 60(10):885-889
22. Pepe A, Positano V, Santarelli MF, Sorrentino F, Cracolici E, De Marchi D, Maggio A, Midiri M, Landini L, Lombardi M (2006) Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 23(5):662-668, May
23. Sahn DJ, De Maria A, Kisslo J, Weyman A (1978) The committee on M-mode standardization of the American Society of Echocardiography: Results of a survey of echocardiogramic measurements. Circulation 58:1072-1083
24. Spirito P, Lupi G, Melevendi C, Vecchio C (1990) Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major. Circulation 82:88-94
25. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ (2006) Thalassemia international federation heart T2* investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 91(10):1388-1391, Oct
26. Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B (2000) Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 110(4):971-977
27. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D (1997) Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 336(19):1350-1355
28. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76(1):44-51